Some patients report fatigue during tirzepatide treatment, particularly during the early treatment phase or with dose escalation, though this is not among the most common adverse events in clinical trials
These results, while promising, require confirmation in the ongoing Phase 3 programme before any conclusions about comparative efficacy can be drawn
Commuting and parking fuel costs to and from the clinic are another hidden expense
Effect of vitrification on meiotic maturation, mitochondrial distribution and glutathione synthesis in immature silver fox cumulus oocyte complexes
Other common gastrointestinal effects include: Diarrhea Constipation Abdominal pain or cramping Bloating and gas Acid reflux or heartburn Decreased appetite (this is both a therapeutic effect and a side effect) Most of these effects are transient
[11] For Kaiser members without coverage, this could provide another self-pay option alongside NovoCare